• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2011 Fiscal Year Final Research Report

Fundamental Research on Hybrids of MRI Contrast Agents and Antitumor Agents to Innovate in Diagnosis and Curing Cancers Efficiently at the Very Early Stage

Research Project

  • PDF
Project/Area Number 21650108
Research Category

Grant-in-Aid for Challenging Exploratory Research

Allocation TypeSingle-year Grants
Research Field Biomedical engineering/Biological material science
Research InstitutionShizuoka University

Principal Investigator

YAMASHITA Mitsuji  静岡大学, 創造科学技術大学院, 特任教授 (60110748)

Co-Investigator(Kenkyū-buntansha) SAKAHARA Harumi  浜松医科大学, 医学部, 教授 (10187031)
TAKEHARA Yasuo  浜松医科大学, 医学部附属病院, 准教授 (70188217)
NAKAMURA Satoki  浜松医科大学, 医学部附属病院, 助教 (20377740)
OKANO Takashi  東京慈恵会医科大学, 医学部, 教授 (90194373)
FUJIE Michio  浜松医科大学, 技術部, 技術専門員 (90397373)
Co-Investigator(Renkei-kenkyūsha) MULLER Robert (MULLER NICOLAS Henry)  University of Mons, Belgium, School of Medicine and Pharmacy, 教授(学部長)
F. DAVID Wiemer  University of Iowa, USA, Department of Medicine, 教授(学部長)
GYORGY Keglevich  Budapest University of Technology and Economics, Hungary, Dept. of Organic Chemistry and Technology, 教授(学部長)
C. SURESH Reddy  Sri Venkateswara University, India, Dept. of Chemistry, 准教授
Project Period (FY) 2009 – 2011
Keywordsがん早期発見 / がん早期治療 / MRI造影剤 / リン糖抗がん剤 / 複合機能化
Research Abstract

The project contained three sub-research thema(1).(3) and the progress of the research was 80% completion.(1) R & D of sugar dendritic Gd-DTAP complex for MRI contrast agents DEN-OH and the modification was 80% successful to develop novel blood pool MRI contrast agents and DEN-OH(prepared via hydrolysis route) drew clear blood vessels and liver cancers. The r1 value for DEN-OH and modified sugar Dendritic Gd-DTPA complexes were 20. 31[mmol-1・s-1], which are superior to clinically used Gd-DTPA(r1=3. 5[mmol-1・s-1]) by 10 times.(2) Phospha sugar antitumor agents were developed. Among them, TBMPP and DBMPP were most active and the analogs showed 10-1000 times more active than Gleevec(clinically used drug). TBMPP suppressed the expression of Cdc25B, which is a common factor of cell cycle for various kinds of cancer cells. Therefore, phospha sugars must most probably be developed as new"Multiple Type Molecular Targeted Antitumor Agents"and the drug may cure various types of cancer patients by the single drug.(3) The application of the results(1) and(2) provided new drugs for diagnosing and curing cancers in the sub-research thema, whose results will not be disclosed at the present stage.

  • Research Products

    (16 results)

All 2012 2011 2010 2009 Other

All Journal Article (10 results) (of which Peer Reviewed: 10 results) Presentation (3 results) Remarks (1 results) Patent(Industrial Property Rights) (2 results)

  • [Journal Article] Synthesis and evaluation of novel phosphasugar anticancer agents2012

    • Author(s)
      Mayumi Yamaoka, Mitsuji Yamashita, Manabu Yamada, Michio Fujie, Keita Kiyofuji, Nobuhisa Ozaki, Kazuhide Asai, Taishi Niimi, Takuya Suyama, Junko Yamashita, Akiho Sawada, Reiko Makita, Masaki Sugiyama, MitsuoToda, Satoki Nakamura, and Kazunori Ohnishi
    • Journal Title

      Pure and Applied Chemistry

      Volume: 84(1) Pages: 37-48

    • Peer Reviewed
  • [Journal Article] Transcriptional repression of Cdc25B byIER5 inhibits the proliferation of leukemic progenitor cells through NF-YB and p300 in acute myeloid leukemia2011

    • Author(s)
      Satoki Nakamura, Yasuyuki Nagata, Lin Tan, Tomonari Takemura, Kiyoshi Shibata, Michio Fujie, Shinya Fujisawa, Yasutaka Tanaka, Mitsuo Toda, Reiko Makita, Kenji Tsunekawa, Manabu Yamada, Mayumi Yamaoka, Junko Yamashita, Kazunori Ohnishi, and Mitsuji Yamashita
    • Journal Title

      PLoS One

      Volume: 6(11)

    • Peer Reviewed
  • [Journal Article] Preparation and evaluation of novel sugar dendritic Gd-DTPA complexes for MRI contrast agents and phosphasugars for anti-tumour agents2011

    • Author(s)
      Keita Kiyofuji, Kenji Tsunekawa, Mitsuji Yamashita, Junko Yamashita, Michio Fujie, Kazuhide Asai, Takuya Suyama, Satoru Ito, Valluru Krishna Reddy, Manabu Yamada, Keisuke Ogawa, Nobuhisa Ozaki, Masaki Sugiyama, Mayumi Yamaoka, Reiko Makita, Satoki Nakamura, Takashi Aoki, Gang Yu, Kengo Aoshima, Nao Kamikage, Yasuo Takehara, Harumi Sakahara, Hisao Takayanagi, Sophie Laurent, Carmen Burtea, Luce Vander Elst, and Robert N. Muller
    • Journal Title

      Advanced Materials Research

      Volume: 222 Pages: 217-220

    • Peer Reviewed
  • [Journal Article] Preparation of phosphosugar analogs and their evaluation as novel anticancer agents2011

    • Author(s)
      Kenji Tsunekawa, Mitsuji Yamashita, Michio Fujie, Taishi Niimi, Takuya Suyama, Kazuhide Asai, SatoruIto, Junko Yamashita, Manabu Yamada, Nobuhisa Ozaki, and Satoki Nakamura
    • Journal Title

      Phosphorus, Sulfur and Silicon and the Related Elements

      Volume: 186(4) Pages: 936-944

    • Peer Reviewed
  • [Journal Article] Preparation and Characterization of Phospha Sugar Analogs, 2, 3-Dibromo-3-methyl-1-phenylphospholane 1-Oxide Derivatives, as Novel Anticancer Agents2010

    • Author(s)
      Manabu Yamada, Kazuhide Asai, Junko Yamashita, Takuya Suyama, Taishi Niimi, Kasthuraiah Maddali, Michio Fujie, Satoki Nakamura, and Mitsuji Yamashita
    • Journal Title

      Phosphorus, Sulfur and Silicon and the Related Elements

      Volume: 185(11) Pages: 2286-2291

    • Peer Reviewed
  • [Journal Article] Preparation and characterization of novel 4-bromo-3, 4-dimethyl-1-phenyl-2-phospholene 1-oxide and the analogous phosphorus heterocycles or phospha sugars2010

    • Author(s)
      Manabu Yamada, Mitsuji Yamashita, Takuya Suyama, Junko Yamashita, Kazuhide Asai, Taishi Niimi, Nobuhisa Ozaki, Michio Fujie, Kasthuraiah Maddali, Satoki Nakamura, and Kazunori Ohnishi
    • Journal Title

      Bioorganic & Medicinal Chemistry Letters

      Volume: 20(19) Pages: 5943-5946

    • Peer Reviewed
  • [Journal Article] Development and pharmacologic characterization of deoxy bromophospha sugar derivatives with antileukemic activity2010

    • Author(s)
      Satoki Nakamura, Mitsuji Yamashita, Daisuke Yokota, Isao Hirano, Takaaki Ono, Michio Fujie, Kiyoshi Shibata, Taishi Niimi, Takuya Suyama, Kasthuraiah Maddali, Kazuhide Asai, Junko Yamashita, Yukiko Iguchi, and Kazunori Ohnishi
    • Journal Title

      Investigational New Drugs

      Volume: 28(4) Pages: 381-391

    • Peer Reviewed
  • [Journal Article] Bioorganic & Medicinal2010

    • Author(s)
      Nobuhisa Ozaki, Arigara Uma Ravi Sankar, Mitsuji Yamashita, Takashi Aoki, Yasutaka Tanaka, Motohiko Kimura, Mitsuo Toda, Michio Fujie, Yasuo Takehara, and Harumi Sakahara
    • Journal Title

      Chemistry Letters

      Volume: 20(3) Pages: 932-934

    • Peer Reviewed
  • [Journal Article] Synthesis of some 1-aryl-2, 3-dibromophospholanesas novel anti-cancer agents2010

    • Author(s)
      Manabu Yamada, Kazuhide Asai, Junko Yamashita, Takuya Suyama, Taishi Niimi, Kasthuraiah Maddali, Michio Fujie, Satoki Nakamura, Motohiko Kimura, Yasutaka Tanaka, Mitsuo Toda, and Mitsuji Yamashita
    • Journal Title

      Heterocyclic Communications

      Volume: 16(2-3) Pages: 173-180

    • Peer Reviewed
  • [Journal Article] Research and development of phospha sugar anti-cancer agents with anti-leukemic activity2010

    • Author(s)
      Junko Yamashita, Takuya Suyama, Kazuhide Asai, Manabu Yamada, Taishi Niimi, Michio Fujie, Satoki Nakamura, Kazunori Ohnishi, and Mitsuji Yamashita
    • Journal Title

      Heterocyclic Communications

      Volume: 16(2-3) Pages: 89-97

    • Peer Reviewed
  • [Presentation] Research and Development of Medicinal Materials for Diagnosing and Curing Cancer(3)-Synthesis and Evaluation of Novel Phospha Sugar Anti-cancer Agents2011

    • Author(s)
      M. Yamashita, et. al.
    • Organizer
      Inter-Academia 2011
    • Place of Presentation
      Alexandru Ioan Cuza University(Sucevita, Romania)
    • Year and Date
      20110900
  • [Presentation] Medicinal Materials for Diagnostic Imaging and Curing Tumors : Syntheses and Evaluation of Sugar-Ball-Dendritic MRI Contrast Agents and Phospha Sugars2011

    • Author(s)
      Mitsuji Yamashita, et. al.
    • Organizer
      21st International Symposium on Glycoconjugates
    • Place of Presentation
      University of Vienna(Vienna, Austria)
    • Year and Date
      20110800
  • [Presentation] Preparation and Evaluation of Novel Phospha Sugars or Phospholanes for Anti-cancer Agents2011

    • Author(s)
      Mayumi Yamaoka, Mitsuji Yamashita, et al
    • Organizer
      23rd International Congress on Heterocyclic Chemistry(ICHC2011)
    • Place of Presentation
      Glasgow Science Centre(Glasgow, Scotland, UK)
    • Year and Date
      20110800
  • [Remarks]

    • URL

      http://shizuoka-6m.web.infoseek.co.jp/yama/yama.htm

  • [Patent(Industrial Property Rights)] 基材の親水化処理方法および親水性基材2011

    • Inventor(s)
      山下光司、小坂友護
    • Industrial Property Rights Holder
      山下光司
    • Industrial Property Number
      特許、特許登録第4703954号
    • Acquisition Date
      2011-03-18
  • [Patent(Industrial Property Rights)] エポキシ誘導体の製造方法2009

    • Inventor(s)
      山下光司
    • Industrial Property Rights Holder
      山下光司
    • Industrial Property Number
      特許、特許登録第4417616号
    • Acquisition Date
      2009-12-04

URL: 

Published: 2013-07-31  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi